Company news
Mayne Pharma Group Ltd. news in 2018
Mayne Pharma Group Ltd.'s news releases, calls and decks from 2018, newest first.
FDA approval of Tolsura (SUBA-itraconazole) capsules
December 11, 2018
2018 AGM CEOs Speech
November 28, 2018
2018 AGM Chairmans Address
November 28, 2018
2018 Full Year Results Investor Presentation
August 23, 2018
2018 Full Year Results Media Release
August 23, 2018
Mayne Pharma acquires generic Efudex in the US
July 22, 2018
SUBA-Itraconazole NDA accepted for review by US FDA
May 1, 2018
Mayne Pharma opens new US manufacturing facility
April 17, 2018
Mayne Pharma launches Amiodarone 200mg tablets in the US
April 16, 2018
Mayne Pharmas generic NuvaRing accepted for filing by FDA
March 19, 2018
Mayne Pharma launches doxycycline IR capsules in the US
March 15, 2018
First generic launch of Ritalin LA 10mg capsules in the US
February 28, 2018
2018 Half Year Investor Presentation
February 22, 2018
2018 Half Year Media Release
February 22, 2018
Decks in 2018
- Merger or Acquisition (October 2018)
Merger or acquisition · 5 slides · Oct 26, 2018
- FY2018 Earnings Presentation
Earnings · 30 slides · Aug 24, 2018
- Investor Presentation (February 2018)
Investor deck · 27 slides · Feb 23, 2018